Ibuprofen
Brand names: Nurofen, Brufen
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used for pain, inflammation and fever.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UKDirections do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 tablet every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 tablet, 2 tablets may be used do not exceed 6 tablets in 24 hours, unless directed by a doctor children under 12 years: ask a doctor
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2026-04-29. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
Ibuprofen non-selectively inhibits cyclo-oxygenase (COX-1 and COX-2), reducing prostaglandin synthesis and thereby pain, inflammation and fever.
Prescribing in practice
- Use the lowest effective dose for the shortest time; gastrointestinal, renal and cardiovascular risks rise with dose and duration.
- Avoid or use caution in peptic ulcer disease, significant renal impairment, heart failure, and uncontrolled hypertension; consider gastroprotection in at-risk patients.
- It reduces the renal clearance of several drugs and adds to bleeding risk with anticoagulants/antiplatelets; the combination with an ACE inhibitor or ARB plus a diuretic is a particular renal risk.
Monitoring
Short courses in healthy adults need no routine monitoring; with longer use or in at-risk patients monitor renal function and blood pressure and review GI symptoms.
Counselling the patient
- Take it with or after food.
- Report indigestion, black stools, or reduced urine output.
- Avoid combining it with other NSAIDs.
Evidence & guidelines
NSAIDs are effective for inflammatory and musculoskeletal pain but are used at the lowest effective dose for the shortest duration because of GI, renal and cardiovascular risk.
Reference: NICE CKS Analgesia; MHRA NSAID safety advice; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023